AlzChem Group AG
ALZCFOTCBasic Materials● Active
$200.15
$-23.10(-10.35%)
Market Cap$2.0B
P/E Ratio—
52W High$223.25
52W Low$137.6
AlzChem Group AG (ALZCF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ALZCF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$2.04
Est. $2.05 · -0.5%
Revenue
$0.17B
Est. $0.17B · +0.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
ALZCF reports quarterly as a OTC-listed Chemicals - Specialty company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$78.12
Rev. $1025.0B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$78.12
Rev. Est.$1025.0B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | — | — | — | — | $0.17B | — |
| — Q2 FY2026 | Apr 30, 2026 | $2.05 | $2.04 | -0.5% | $0.17B | $0.17B | +0.2% |
| — Q1 FY2026 | Feb 27, 2026 | $1.95 | $1.95 | +0.0% | $0.16B | $0.17B | -4.8% |
| — Q4 FY2025 | Oct 29, 2025 | — | $1.89 | — | $0.16B | $0.16B | +0.3% |
| — Q3 FY2025 | Jul 30, 2025 | — | $1.84 | — | $0.17B | $0.34B | -50.1% |
| — Q2 FY2025 | Apr 30, 2025 | — | $1.58 | — | $0.16B | — | — |
| — Q1 FY2025 | Feb 28, 2025 | — | $1.54 | — | $0.14B | $0.15B | -5.2% |
| — Q4 FY2024 | Nov 7, 2024 | — | $1.33 | — | $0.14B | — | — |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026
EPS Actual
$2.04
EPS Est.
$2.05
EPS Surpr.
-0.5%
Revenue
$0.17B
Q1 FY2026
Feb 27, 2026
EPS Actual
$1.95
EPS Est.
$1.95
EPS Surpr.
+0.0%
Revenue
$0.16B
Q4 FY2025
Oct 29, 2025
EPS Actual
$1.89
EPS Est.
—
EPS Surpr.
—
Revenue
$0.16B
Q3 FY2025
Jul 30, 2025
EPS Actual
$1.84
EPS Est.
—
EPS Surpr.
—
Revenue
$0.17B
Q2 FY2025
Apr 30, 2025
EPS Actual
$1.58
EPS Est.
—
EPS Surpr.
—
Revenue
$0.16B
Q1 FY2025
Feb 28, 2025
EPS Actual
$1.54
EPS Est.
—
EPS Surpr.
—
Revenue
$0.14B
Q4 FY2024
Nov 7, 2024
EPS Actual
$1.33
EPS Est.
—
EPS Surpr.
—
Revenue
$0.14B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2026 | $3.08 | $3.08 | $3.08 | 1 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $1.78 | $1.78 | $1.78 | 1 |
| Q4 FY2025 | $1.66 | $1.66 | $1.66 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 2 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | -0.5% | $217.10 | $217.10 | +0.00% |
| ▲ Q1 FY2026 | Feb 27, 2026 | +0.0% | $182.02 | $182.02 | +0.00% |
| — Q4 FY2025 | Oct 29, 2025 | — | $181.33 | $181.32 | -0.01% |
| — Q3 FY2025 | Jul 30, 2025 | — | $174.46 | $152.50 | -12.59% |
| — Q2 FY2025 | Apr 30, 2025 | — | $101.30 | $126.50 | +24.88% |
| — Q1 FY2025 | Feb 28, 2025 | — | $58.60 | $58.60 | +0.00% |
| — Q4 FY2024 | Nov 7, 2024 | — | $48.49 | $48.49 | +0.00% |
| — Q3 FY2024 | Aug 1, 2024 | — | $51.40 | $51.40 | +0.00% |
Q2 FY2026+0.00%
Report Date
Apr 30, 2026
EPS Beat/Miss
-0.5%
Price Before
$217.10
Price After
$217.10
Q1 FY2026+0.00%
Report Date
Feb 27, 2026
EPS Beat/Miss
+0.0%
Price Before
$182.02
Price After
$182.02
Q4 FY2025-0.01%
Report Date
Oct 29, 2025
EPS Beat/Miss
—
Price Before
$181.33
Price After
$181.32
Q3 FY2025-12.59%
Report Date
Jul 30, 2025
EPS Beat/Miss
—
Price Before
$174.46
Price After
$152.50
Q2 FY2025+24.88%
Report Date
Apr 30, 2025
EPS Beat/Miss
—
Price Before
$101.30
Price After
$126.50
Q1 FY2025+0.00%
Report Date
Feb 28, 2025
EPS Beat/Miss
—
Price Before
$58.60
Price After
$58.60
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
—
Price Before
$48.49
Price After
$48.49
Q3 FY2024+0.00%
Report Date
Aug 1, 2024
EPS Beat/Miss
—
Price Before
$51.40
Price After
$51.40
Avg Beat Reaction+0.00%
Beat Rate2 / 8 quarters
Largest Move+24.88% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ALZCF ends December
AlzChem Group AG (ALZCF) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $2.04 (in line with the analyst consensus of $2.05). The next ALZCF earnings date is expected around September 1, 2026.
Each quarter, investors track ALZCF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ALZCF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ALZCF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ALZCF earnings · 4 questionsAlzChem Group AG's next earnings report is expected around September 1, 2026. ALZCF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ALZCF historically reports after market close (AMC).
ALZCF earnings datewhen is ALZCF earningsALZCF next earnings datewhen does ALZCF report earningsALZCF earnings calendar
▸ Source: FMP · AlzChem Group AG SEC filings · US GAAP · AlzChem Group AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026